Nectar
Year2023
RoundSeries A
Amount$16.5M
Overall
Summary
34 slides
34 slides
1 slide
Introducing Nectar, the future of allergy care.
10 slides
Allergies affect 120 million Americans, but existing care methods are insufficient, leading to a negative Net Promoter Score and resulting in significant healthcare costs and lost productivity.
8 slides
Nectar offers a hybrid allergy care platform combining in-clinic visits with at-home treatments, personalized symptom management, and innovative testing methods to improve patient experience.
5 slides
With allergies being the #1 chronic condition and a $450 billion market, there is a significant opportunity for comprehensive allergy solutions that address consumer pain points.
3 slides
Nectar utilizes proprietary technology for fast allergy testing and an in-house pharmacy to provide effective personalized treatments delivered conveniently to users.
3 slides
Led by experienced founder Ken Chahine, the Nectar team boasts a diverse background in healthcare, supply chain, and e-commerce to effectively tackle the allergy care challenge.
2 slides
Together, we can put an end to allergies—thank you for considering Nectar.
